Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: Hong Kong Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20042
20061
20072
20086
20099
201013
20112
20122
20133
20141
20154
20161
20175
20185
20192
20205
20214
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S16
Chinese University of Hong Kong9
Boehringer Ingelheim7
Hoffmann-La Roche7
The University of Hong Kong6
AstraZeneca4
GlaxoSmithKline4
Sanofi4
Bayer3
Takeda3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 275
Diabetes Mellitus20
Diabetic Nephropathies3
Obesity3
Acute Coronary Syndrome2
Coronary Artery Disease2
Diabetes Mellitus, Type 12
Glucose Intolerance2
Kidney Diseases2
Non-alcoholic Fatty Liver Disease2

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.